A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...

Yunu, the creator and leader in cloud-native imaging workflows for clinical trials, today announced a major new software ...

Social proof—seeing peers safely participate—reduces fear and builds trust in clinical trials. Sharing real stories and ...

The liposarcoma pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage liposarcoma drugs, inactive and dormant assets, a comprehensive ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

WASHINGTON D.C. (ANI) – Researchers at the University of California San Diego and Wake Forest University have found that both ...

Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

A new generation of medical data aggregators is using AI to offer health care professionals a different kind of interface and ...

Title: OPERA-01: A randomized, open-label, phase 3 study of palazestrant (OP-1250) monotherapy vs standard-of-care endocrine therapy for patients with ER+, HER2- advanced breast cancer after endocrine ...

A local cancer treatment center is giving patients across West Texas renewed hope by highlighting the life-saving potential of clinical trials.

Olipop is leading the pre-biotic beverage trend, sparking the likes of Coca Cola and PepsiCo to enter the fray.